Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg

Transplantation

Volumn 71, Issue 7, 2001, Pages 986-992

  Gillmore, Julian D ^a   Stangou, Arie J ^b   Tennent, Glenys A ^a   Booth, David R ^a   O'Grady, John ^b   Rela, Mohamed ^b   Heaton, Nigel D ^b   Wall, Catherine A ^c   Keogh, J A Brian ^c   Hawkins, Philip N ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; APOLIPOPROTEIN A1; ARGININE; GLYCINE;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FOLLOW UP; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; TURNOVER TIME;

EID: 0035870770     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200104150-00026     Document Type: Article

References (39)

1. Demonstration einer eigenartigen familiaren paraamyloidose
2. New USA family has apolipoprotein AI (Arg26) variant
3. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis
4. A new apolipoprotein AI variant, Trp50Arg, causes hereditary amyloidosis
5. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene
6. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I
7. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1
8. A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis
9. 174 ->Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide
10. Human lysozyme gene mutations cause hereditary systemic amyloidosis
11. Hereditary renal amyloidosis associated with a mutant fibrinogen α-chain
12. Hereditary renal amyloidosis with a novel variant fibrinogen
13. A frame shift mutation in the fibrinogen Aα-chain gene in a kindred with renal amyloidosis
14. Renal amyloidosis with a frame shift mutation in fibrinogen Aα-chain gene producing a novel amyloid protein
15. Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component
16. 123I-labeled serum amyloid P component
17. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis
18. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo
19. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: Regression of visceral amyloid following liver transplantation
20. Allogeneic bone marrow transplantation for systemic AL amyloidosis
21. Synthesis and secretion of apolipoprotein A-I
22. Congo red overlay immunohistochemistry aids classification of amyloid deposits
23. Imaging amyloidosis with radiolabelled SAP
24. x instrument
25. Apolipoprotein AI isoforms in serum determined by isoelectric focusing and immunoblotting
26. Inherited predisposition to generalized amyloidosis
27. Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26
28. A new deletion mutation of the apolipoprotein AI gene causing hereditary amyloidosis
29. Fifteen years' experience with renal transplantation in systemic amyloidosis
30. Twenty-one years survival with systemic AL amyloidosis
31. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival
32. Combined liver and kidney transplantation
33. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report
34. Combined hepatic and renal transplantation in primary hyperoxaluria type I: Clinical report of nine cases
35. Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient
36. Systemic chimerism in human female recipients of male livers
37. Long-term results of combined kidney and liver transplantation at one center
38. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α-chain variant in an English family
39. Iowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis